Effect of the glutamate NMDA receptor antagonist memantine as adjunctive treatment in borderline personality disorder: an exploratory, randomised, double-blind, placebo-controlled trial - Kulkarni, J; Thomas, N; Hudaib, A R (CNS Drugs, 2018)
et al.